MADISON HEIGHTS, Mich., Aug. 7, 2015 /PRNewswire/ -- The Editorial Advisory and Securities Review Committee of BetterInvesting Magazine today announced Delta Air Lines, Inc. (NYSE: DAL) as its October 2015 "Stock to Study" and Biogen Inc. (NDQ: BIIB) as its October 2015 "Undervalued Stock" for investors' informational and educational use.
"The committee selected Delta Air Lines for its high expected earnings growth over the next five years combined with reasonable valuation," said Adam Ritt, editor of BetterInvesting Magazine. "For the Undervalued selection, the committee cited Biogen's current price-earnings ratio, which is lower than many of its biotech peers, and strong growth opportunities." Check BetterInvesting's October issue for more details about these selections.
Committee members are Kenneth M. Bernard, CFA; Robert M. Bilkie, Jr., CFA; Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip S. Dano, CFA; Donald E. Danko, CFA; Maury Elvekrog, CFA; and Walter J. Kirchberger, CFA.
As stated, the BetterInvesting committee's Stock to Study and Undervalued Stock choices are for the informational and educational uses of investors and are not intended as investment recommendations. BetterInvesting urges investors to educate themselves about the stock market so they can make informed decisions about stock purchases.
About BetterInvesting BetterInvesting is a national nonprofit organization that has been empowering individual investors since 1951. Founded in Detroit, the association (formerly known as National Association of Investors Corporation) was borne out of the conviction that anyone can become a successful long-term investor by following commonsense investing practices. BetterInvesting has helped more than 5 million people become better, more informed investors by providing webinars, in-person events, easy-to-use online tools for analyzing stocks, a monthly magazine and a community of volunteers and like-minded investors. For more information about BetterInvesting, visit its website at www.betterinvesting.org or call toll free (877) 275-6242.